Baird Financial Group
KITE

Baird Financial Group’s Kite Pharma, Inc. KITE Stock Holding History

Baird Financial Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-27,639
Closed -$1.54M – 1290
2016
Q3 		$1.54M Sell
27,639
-2,671
-9% -$149K 0.01% 625
2016
Q2 		$1.51M Sell
30,310
-6,179
-17% -$304K 0.01% 626
2016
Q1 		$1.68M Buy
36,489
+11,583
+47% +$561K 0.02% 584
2015
Q4 		$1.53M Buy
24,906
+1,721
+7% +$121K 0.02% 594
2015
Q3 		$1.29M Buy
23,185
+129
+0.6% +$8.11K 0.01% 631
2015
Q2 		$1.41M Buy
+23,056
New +$1.32M 0.01% 640

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Baird Financial Group's KITE Position: Q4 2016 in Review

Baird Financial Group sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 27,639 shares — an estimated $1.54M sold.

Baird Financial Group first reported a position in KITE in Q2 2015 and held it in 6 quarters. The position peaked at $1.68M in Q1 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

  • Baird Financial Group reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
  • Baird Financial Group sold 27,639 Kite Pharma, Inc. shares in Q4 2016, an estimated $1.54M.
  • Baird Financial Group first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 6 quarters.
  • Baird Financial Group's Kite Pharma, Inc. position peaked at $1.68M in Q1 2016.
  • 184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Baird Financial Group's 13F filing for Q4 2016, filed 10 Feb 2017.